Mr. Speaker, on the issue of hepatitis C, the government has made it very clear about the issue of compensation.
The hon. member knows that originally there were certain years where compensation was going to be awarded. It was due to the fact that it could only be based on the information available at that time. The minister has made an announcement with regard to the issue of compensation across the board. Clearly, the member has an interest in this issue. However, the government has made its plans clear.
This member may not agree with the form or the type of compensation that is being offered. However, I would point out to the member that what is important is the long-term assistance for individuals affected by hepatitis C. It is very important that the financial resources be there for the health of those individuals, particularly in the area of drugs which can be, and I am sure the member knows, very expensive. That kind of compensation and that kind of assistance to deal in the long-term with the hepatitis C issue is extremely important.